Highlights
-
Rare diseases: Telethon-Cariplo funds two research projects at HT
Two research projects from Human Technopole have won the Fondazione Telethon and Cariplo grant to uncover the genetic and molecular mechanisms of acute myeloid leukemia and congenital adrenal hyperplasia. The projects, led by Alice Giustacchini (Group Leader of Genomics) and Emanuele Villa and Nicolò Caporale (Testa Group, Neurogenomics), have been respectively funded with €230,000 and €250,000.
-
Human Technopole Celebrates its First PhDs
Three young scientists from Human Technopole have, for the first time since its foundation, obtained a doctoral degree while pursuing their research within the institute: Alessandro Vinceti, Davide Castaldi, and Marco Tullio Rigoli, all enrolled in the systems medicine programme of the European School of Molecular Medicine (SEMM).
-
SINEUP long non-coding RNAs: when structure meets function
Human Technopole and RIKEN researchers identify conserved short structural motifs within natural SINE-transcribed RNAs that enhance target mRNAs’ transcription, thus shedding new light on the SINEUPs’ function.
-
Role of inherited genetic variants in rare blood cancer uncovered
Combining three different sources of genetic information has allowed researchers to further understand why only some people with a common mutation go on to develop rare blood cancer
-
Hundreds of new targets accelerate cancer drug discovery
The second generation of the Cancer Dependency Map uncovers 370 priority drug targets, with strong links to specific cancer types.
Research at HT
Improving human health and well-being is the ultimate goal of Human Technopole. We need to prevent and cure diseases to allow people of all ages to not only live longer, but also live better.
Discover more about our:
Thanks to a comprehensive and interdisciplinary approach to the study of human biology, HT’s research aims to understand the mechanisms underlying various diseases, exploiting the technological advances of the last decade and the enormous amount of biological, clinical and socio-economic data currently available to improve the national healthcare system and the quality of life of all citizens.
Human Technopole’s research is based on five interdisciplinary research areas: Genomics, Neurogenomics, Structural Biology, Computational Biology and Health Data Science.
Starting from early 2024, Human Technopole will be opening the first National Facilities available to the national scientific community to carry out top-level research in their respective fields.
Work with us
We offer the opportunity to be part of a new, dynamic research institute promoting a highly collaborative and international working environment.
We aim to attract the best resources in each field with a selection based on merit and transparency as we believe that highly diverse teams produce the best and most innovative results.
If you are a passionate person who likes to seize great challenges, consider applying for one of our scientific or administrative vacancies.